Trial Profile
68Ga-PSMA-11 PET/CT in men with newly diagnosed prostate cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2018
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 13 Aug 2018 New trial record
- 03 Aug 2018 Results published in the BJU International